FIELD: medicine.
SUBSTANCE: to reduce isoniazid neurotoxicity experimentally, the treatment with isoniazid is combined with administering vitamin B6 and taurine in isoniazid:vitamin B6:taurine ratio - 200:1.3-3.9:255.
EFFECT: invention provides preventing and treating neurotoxic responses to antituberculosis agents in developing new therapeutic approaches to tuberculosis experimentally.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
3-BENZYLAMINOMETHYLENEPYRROLIDINE-2,4-DIONE AND ANTICONVULSANT AGENT BASED ON SAID | 1997 |
|
RU2144918C1 |
METHOD FOR REDUCING NEUROTOXICITY CAUSED BY A COMPLEX OF ANTI-TUBERCULOSIS DRUGS IN EXPERIMENT | 2023 |
|
RU2820957C1 |
METHOD FOR MODELING EPILEPTIC STATUS | 0 |
|
SU1709380A1 |
METHOD FOR PREVENTION OF COMPLICATIONS INDUCED BY ISONIAZID | 2015 |
|
RU2597788C1 |
METHOD FOR MODELING DRUG NEUROTOXICITY USING COMPLEX OF ANTI-TUBERCULOSIS AND ANTIMICROBIAL DRUGS | 2022 |
|
RU2795524C1 |
MEDICINAL AGENT OFFERING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTICONVULSANT EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2309745C2 |
DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2457212C1 |
METHOD OF TREATMENT LARVAL ECHINOCOCCOSIS OF LABORATORY ANIMALS | 2013 |
|
RU2517044C1 |
DIALKYL(2-METHYL-4-OXOPENT-2-YL)PHOSPHINE OXIDE PYRIDINOYL HYDRAZONES, HAVING ANTITUBERCULOUS ACTIVITY | 2012 |
|
RU2498990C1 |
Authors
Dates
2016-01-27—Published
2014-12-15—Filed